Diastat and X-ray limb abnormal - a phase IV clinical study of FDA data
We study 1,909 people who take Diastat or have X-ray limb abnormal. No report of X-ray limb abnormal is found in people who take Diastat.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Diastat?
Diastat has active ingredients of diazepam. eHealthMe is studying from 1,791 Diastat users for its effectiveness, alternative drugs and more.
What is X-ray Limb Abnormal?
X-ray limb abnormal is found to be associated with 256 drugs and 109 conditions by eHealthMe.
Do you take Diastat and have X-ray limb abnormal?Check whether X-ray limb abnormal is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was X-ray limb abnormal and when was it recovered:
Expand to all the drugs that have ingredients of diazepam:
Alternative drugs to, pros and cons of Diastat:
- Diastat (1,791 reports)
X-ray limb abnormal treatments and more:
- X-ray limb abnormal (118 reports)
COVID vaccines that are related to X-ray limb abnormal:
- X-ray limb abnormal in Moderna COVID Vaccine
- X-ray limb abnormal in Pfizer BioNTech Covid Vaccine
- X-ray limb abnormal in Johnson and Johnson Covid Vaccine
All the drugs that are associated with X-ray limb abnormal:
All the conditions that are associated with X-ray limb abnormal:
How the study uses the data?
The study uses data from the FDA. It is based on diazepam (the active ingredients of Diastat) and Diastat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Zonisamide and Acute Hepatic Failure - now
- Osteoporosis Post-Menopausal and Spinal Fracture - a second ago
- Dilaudid and Vitamin B12 Deficiency - 4 seconds ago
- Verapamil Hcl and Dysstasia - 8 seconds ago
- Folic Acid and Wound Complication - 9 seconds ago
- Soma and Lymphadenopathy Mediastinal - 10 seconds ago
- Claritin-D and Vimpat drug interaction - 11 seconds ago
- Exelon and Hypertensive Crisis - 18 seconds ago
- Selenium and Enlarged Prostate - 18 seconds ago
- Cenestin and Advair Diskus 100/50 drug interaction - 22 seconds ago